Vera Hirsh
Researcher Next ID · RN-014346
Researcher · Medicine
Taipei Veterans General Hospital
, Taiwan
- Works count
- 267
- Citation count
- 33,156
- H-index
- 61
- i10-index
- 135
Research interests
Publications
Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials
The Lancet Oncology · 2015 · 10.1016/s1470-2045(14)71173-8
Crizotinib versus Chemotherapy in Advanced ALK -Positive Lung Cancer
New England Journal of Medicine · 2013 · 10.1056/nejmoa1214886
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
Journal of Clinical Oncology · 2013 · 10.1200/jco.2012.44.2806
Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer: AVAiL
Journal of Clinical Oncology · 2009 · 10.1200/jco.2007.14.5466
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
New England Journal of Medicine · 2005 · 10.1056/nejmoa050753
Current projects
No projects listed.